0.05Open0.10Pre Close44 Volume217 Open Interest45.00Strike Price259.00Turnover75.40%IV18.82%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0108Delta0.0102Gamma3788.00Leverage Ratio-0.0078Theta0.0000Rho40.72Eff Leverage0.0010Vega
CRISPR Therapeutics Stock Discussion
For example, companies like $Zscaler (ZS.US)$ and $Datadog (DDOG.US)$ are leaders in cloud-based cybersecurity and monitorin...
This tariffs move is affecting everything, as per Trump interview yesterday, one News Anchor ask about when does Trump expect the economy to recover, he said about 2 years…. We might expect more Red this year, hope the market will recover sooner.
What's Fueling HIMS' Rally?
HIMS surged 17.5% on Wednesday following the announcement of an acquisition, reaching an intraday high of nearly 25% and hitting a record $72.
Hims & Hers disclosed it acquired Sigmund NJ LLC, also known as Trybe La...
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...
No comment yet